Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 32, 2018 - Issue 15
275
Views
8
CrossRef citations to date
0
Altmetric
Short Communication

Secondary metabolites from endemic species Iris adriatica Trinajstić ex Mitić (Iridaceae)

, , , &
Pages 1849-1852 | Received 31 Aug 2017, Accepted 03 Nov 2017, Published online: 10 Nov 2017
 

Abstract

This manuscript describes the first detailed chemical investigation of endemic species Iris adriatica, including isolation and structure elucidation. Chemical analyses of the rhizome CH2Cl2/MeOH (2:1) extract revealed fourteen secondary metabolites, mainly isoflavonoids. Among isoflavonoids, two groups have been found: nigricin-type and tectorigenin-type. Dominant group of the isolated compounds has been nigricin-type isoflavones: nigricin, nigricin-4′-(1-O-β-D-glucopyranoside) and nigricin-4′-(1-O-β-D-glucopyranosyl (1–6)-β-D-glucopyranoside) with 2.5, 10 and 1% of the total extract, respectively. Irisxanthone – xanthone C-glucoside, β-sitosterol, benzophenone and one of its derivatives have also been found. Nigricin-type isoflavonoids and irisxanthone can be considered as possible chemotaxonomic markers for I. adriatica. 5,3′,5′-Trimethoxy-6,7-methylenedioxyisoflavone-4′-(1-O-β-D-glucopyranoside) and benzophenone have been isolated from Iris species for the first time.

Left-hand image of Iris adriatica (Adriatic potato) with redditsh purple flowers © Miroslav Mitić. All Rights Reserved.

View correction statement:
Corrigendum for Secondary metabolites from endemic species Iris adriatica Trinajstić ex Mitić (Iridaceae)

Acknowledgements

Authors are grateful to Dr. Yasuko Okamoto (Faculty of Pharmaceutical Sciences, Tokushima Bunri University) for the MS analysis.

Notes

This article was originally published with errors. This version has been amended. Please see Corrigendum (https://doi.org/10.1080/10.1080/14786419.2018.1448526).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.